|
|
GBC |
CURRENT ISSUE: 2009, Volume 8, Number 2 |
|
PERSPECTIVE |
 |
Personalized Molecular cancer-targeted therapy
Why novel causal network-based biomarkers and new targeted agents are needed and how to overcome challenges.
more... |
|
 |
|
Anti-VEGF Agents (Bevacizumab) Limitations
What reveal latest high-quality experimental and clinical studies suggesting caution in the clinical use of anti-VEGF agents? Why should oncologists carefully consider these data? more... |
|
 |
|
| Impact of genetics and genomics in breast cancer surgery more... |
|
 |
REVOLUTION IN SURGERY |
Laparoscopic & robotic approaches change oncological practice
Improving dramatically quality of life. Butvwhat are the risks? |
|
| EDITORIAL: New era in cancer surgical treatment |
|
| NEWS & VIEWS: Rectal cancer resection |
|
| NEWS & VIEWS: Laparoscopic Colectomy for Colon Cancer |
|
 |
|
Personal genomics for early Breast cancer
How targeted therapy, genetics and personal genomics may prevent local failures and improve Local outcomes.
more... |
|
GBC |
PAST ISSUE |
|
|
| |
|
|
|
PERSONALIZED MEDICINE |
CANCER HETEROGENITY REQUIRES
PERSONALIZED CANCER CARE |
| |
|
1. BACKGROUND |
Multiple genetic alterations &
signaling pathways network
|
 |
Science, Jones, 2008, Pancreatic cancer |
 |
Science, Wood, 2007, Breast & Colon cancer |
| Genotype-Phenotype map |
 |
Nature, Rockman, 2008 |
| |
| 2. Personalized care |
| PERSONALIZED vs COMPARATIVE-EFFECTIVENESS RESEARCH
|
 |
N Engl J Med, Garber, 2009 |
| |
| SYSTEMS BIOLOGY |
| networks modelling
|
 |
Nature, Bastiaens, 2009 |
 |
Molecular Systems Biology, Deisboeck, 2009 |
 |
Exp Rev Mol Diagn, Roukos, 2009 |
|
|